These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 28928267)

  • 21. Boston type 1 keratoprosthesis for primary congenital glaucoma.
    Haugsdal JM; Goins KM; Greiner MA; Kwon YH; Alward WL; Wagoner MD
    Br J Ophthalmol; 2016 Mar; 100(3):328-31. PubMed ID: 26206789
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Differential Impact of Age on Vision-Related Quality of Life across the Visual Impairment Spectrum.
    Man REK; Gan ATL; Fenwick EK; Gupta P; Thakur S; Fang XL; Cheng CY; Wong TY; Lamoureux EL
    Ophthalmology; 2021 Mar; 128(3):354-363. PubMed ID: 32738259
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Short-term visual outcomes of Boston type 1 keratoprosthesis implantation.
    Dunlap K; Chak G; Aquavella JV; Myrowitz E; Utine CA; Akpek E
    Ophthalmology; 2010 Apr; 117(4):687-92. PubMed ID: 20096462
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Boston Type 1 Keratoprosthesis for Gelatinous Drop-Like Corneal Dystrophy.
    Lekhanont K; Jongkhajornpong P; Chuephanich P; Inatomi T; Kinoshita S
    Optom Vis Sci; 2016 Jun; 93(6):640-6. PubMed ID: 26990741
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcomes and complications of Boston keratoprosthesis type I implantation in unilateral versus bilateral corneal blindness.
    Touma S; Harissi-Dagher M
    Can J Ophthalmol; 2021 Apr; 56(2):130-136. PubMed ID: 33002416
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gamma-irradiated corneas as carriers for the Boston type 1 keratoprosthesis: advantages and outcomes in a surgical mission setting.
    Fadlallah A; Atallah M; Cherfan G; Awwad ST; Syed ZA; Melki SA
    Cornea; 2014 Mar; 33(3):235-9. PubMed ID: 24457451
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Visual Outcomes and Complications of Type I Boston Keratoprosthesis in Children: A Retrospective Multicenter Study and Literature Review.
    Fung SSM; Jabbour S; Harissi-Dagher M; Tan RRG; Hamel P; Baig K; Ali A
    Ophthalmology; 2018 Feb; 125(2):153-160. PubMed ID: 28807636
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patient-Reported Vision-Related Quality of Life After Boston Type I Keratoprosthesis.
    Bostan C; Elfekhfakh M; Harissi-Dagher M
    Cornea; 2020 Feb; 39(2):222-228. PubMed ID: 31490275
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary implantation of type I Boston keratoprosthesis in nonautoimmune corneal diseases.
    Chang HY; Luo ZK; Chodosh J; Dohlman CH; Colby KA
    Cornea; 2015 Mar; 34(3):264-70. PubMed ID: 25611395
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-Term Visual Outcomes, Complications, and Retention of the Boston Type I Keratoprosthesis.
    Aravena C; Yu F; Aldave AJ
    Cornea; 2018 Jan; 37(1):3-10. PubMed ID: 28990994
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Boston keratoprosthesis in the management of corneal limbal stem cell deficiency.
    Sejpal K; Yu F; Aldave AJ
    Cornea; 2011 Nov; 30(11):1187-94. PubMed ID: 21885964
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The Boston keratoprosthesis in the management of corneal blindness: Indications and limitations].
    Stolowy N; Callet M; Beylerian M; Hoffart L; Yin GHW
    J Fr Ophtalmol; 2018 Sep; 41(7):642-649. PubMed ID: 30170706
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Boston keratoprosthesis type II: the Massachusetts Eye and Ear Infirmary experience.
    Pujari S; Siddique SS; Dohlman CH; Chodosh J
    Cornea; 2011 Dec; 30(12):1298-303. PubMed ID: 21963861
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blood Levels of Tumor Necrosis Factor Alpha and Its Type 2 Receptor Are Elevated in Patients with Boston Type I Keratoprosthesis.
    Paschalis EI; Taniguchi EV; Chodosh J; Pasquale LR; Colby K; Dohlman CH; Shen LQ
    Curr Eye Res; 2019 Jun; 44(6):599-606. PubMed ID: 30632412
    [No Abstract]   [Full Text] [Related]  

  • 35. Complications associated with Boston keratoprosthesis type 1 and glaucoma drainage devices.
    Robert MC; Pomerleau V; Harissi-Dagher M
    Br J Ophthalmol; 2013 May; 97(5):573-7. PubMed ID: 23435225
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Boston Keratoprosthesis Type 1: A Randomized Controlled Trial of Fresh versus Frozen Corneal Donor Carriers with Long-Term Follow-up.
    Muzychuk AK; Robert MC; Dao S; Harissi-Dagher M
    Ophthalmology; 2017 Jan; 124(1):20-26. PubMed ID: 27566854
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Boston keratoprosthesis in Stevens-Johnson syndrome.
    Sayegh RR; Ang LP; Foster CS; Dohlman CH
    Am J Ophthalmol; 2008 Mar; 145(3):438-44. PubMed ID: 18207122
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Medium-term outcomes of boston type 1 keratoprosthesis implantation in Bangkok, Thailand.
    Lekhanont K; Thaweesit P; Muntham D; Chuckpaiwong V; Vongthongsri A
    Cornea; 2014 Dec; 33(12):1312-9. PubMed ID: 25285588
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Aurolab Keratoprosthesis (KPro) versus the Boston Type I Kpro: 5-year Clinical Outcomes in 134 Cases of Bilateral Corneal Blindness.
    Basu S; Serna-Ojeda JC; Senthil S; Pappuru RR; Bagga B; Sangwan V
    Am J Ophthalmol; 2019 Sep; 205():175-183. PubMed ID: 30905723
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Boston type 1 keratoprosthesis for failed keratoplasty.
    Hager JL; Phillips DL; Goins KM; Kitzmann AS; Greiner MA; Cohen AW; Welder JD; Wagoner MD
    Int Ophthalmol; 2016 Feb; 36(1):73-78. PubMed ID: 25975459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.